🇺🇸 TG4001 in United States
1 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 20 April 2025 – 20 April 2026
- Total reports: 1
Most-reported reactions
- Central Nervous System Vasculitis — 1 report (100%)
Frequently asked questions
Is TG4001 approved in United States?
TG4001 does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for TG4001 in United States?
Pfizer Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.